Andrew J. Armstrong
2007–2026 年に発表
- 191
- 論文数
- 29,246
- 被引用数
- 72
- h 指数
- 168
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Medicine77%
- Biochemistry, Genetics and Molecular Biology16.4%
- Immunology and Microbiology2.1%
- Computer Science1.1%
- Engineering1.1%
- Mathematics0.3%
- その他2%
トピック
- Prostate Cancer Treatment and Research19%
- Prostate Cancer Diagnosis and Treatment10.6%
- Radiopharmaceutical Chemistry and Applications5%
- Cancer, Lipids, and Metabolism3.2%
- Cancer Genomics and Diagnostics3.2%
- Cancer Cells and Metastasis3.1%
- その他55.9%
共著者
- Daniel J. George47
- Susan Halabi31
- Neal D. Shore29
- Emmanuel S. Antonarakis27
- Michael J. Morris23
- Fred Saad22
- Karim Fizazi22
- Tian Zhang22
- Daniel P. Petrylak21
- Oliver Sartor21
- Himisha Beltran20
- Johann S. de Bono20
- Celestia S. Higano18
- Michael R. Harrison18
- Russell Z. Szmulewitz18
- Eric J. Small17
- Tomasz M. Beer17
- Rana R. McKay16
- Howard I. Scher15
- Arnulf Stenzl14
- Monika Anand14
- Cora N. Sternberg13
- Michael A. Carducci13
- Scott T. Tagawa13
全論文
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
著者: Howard I. Scher, Karim Fizazi, Fred Saad, Mary‐Ellen Taplin, Cora N. Sternberg, Kurt Miller, Ronald de Wit, Peter F.A. Mulders, Kim N., Neal D. Shore, Andrew J. Armstrong, Thomas W. Flaig, Aude Fléchon, Paul N. Mainwaring, Mark T. Fleming, John D. Hainsworth, Mohammad Hirmand, Bryan Selby, Lynn Seely, Johann S. de Bono - New England Journal of Medicine 2012 被引用: 4,574
- Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
著者: Howard I. Scher, Michael J. Morris, Walter M. Stadler, Celestia S. Higano, Ethan Basch, Karim Fizazi, Emmanuel S. Antonarakis, Tomasz M. Beer, Michael A. Carducci, Kim N., Paul G. Corn, Johann S. de Bono, Robert Dreicer, Daniel J. George, Elisabeth I. Heath, Maha Hussain, Wm. Kevin Kelly, Glenn Liu, Christopher J. Logothetis, David M. Nanus, Mark N. Stein, Dana E. Rathkopf, Susan F. Slovin, Charles J. Ryan, Oliver Sartor, Eric J. Small, Matthew Raymond Smith, Cora N. Sternberg, Mary-Ellen Taplin, George Wilding, Peter S. Nelson, Lawrence H. Schwartz, Susan Halabi, Philip W. Kantoff, Andrew J. Armstrong - Journal of Clinical Oncology 2016 被引用: 1,603
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
著者: Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf, Yohann Loriot, Cora N. Sternberg, Celestia S. Higano, Peter Iversen, Suman Bhattacharya, Joan Carles, Simon Chowdhury, Ian D. Davis, Johann S. de Bono, Christopher P. Evans, Karim Fizazi, Anthony M. Joshua, Choung‐Soo Kim, Go Kimura, Paul N. Mainwaring, Harry H. Mansbach, Kurt Miller, Sarah B. Noonberg, Frank Perabo, De Phung, Fred Saad, Howard I. Scher, Mary‐Ellen Taplin, Peter Venner, Bertrand Tombal - New England Journal of Medicine 2014 被引用: 3,031
- ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
著者: Andrew J. Armstrong, Russell Z. Szmulewitz, Daniel P. Petrylak, Jeffrey M. Holzbeierlein, Arnauld Villers, Arun Azad, Antonio Alcaraz, B. Yа. Alekseev, Taro Iguchi, Neal D. Shore, Brad Rosbrook, Jennifer Sugg, Benoît Baron, Lucy Chen, Arnulf Stenzl - Journal of Clinical Oncology 2019 被引用: 1,186
- Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer
著者: Noel W. Clarke, Andrew J. Armstrong, Antoine Thiery-Vuillemin, Mototsugu Oya, Neal D. Shore, Eugenia Loredo, Giuseppe Procopio, Juliana de Menezes, Gustavo Girotto, Çağatay Arslan, Niven Mehra, Francis Parnis, Emma Brown, Friederike Schlürmann, Jae Young Joung, Mikio Sugimoto, Juan Antonio Virizuela, Urban Emmenegger, Jiří Navrátil, Gary L. Buchschacher, Christian Poehlein, Elizabeth A. Harrington, Chintu Desai, Jinyu Kang, Fred Saad - NEJM Evidence 2022 被引用: 394
- Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial
著者: Fred Saad, Noel W. Clarke, Mototsugu Oya, Neal D. Shore, Giuseppe Procopio, João Daniel Guedes, Cagatay Arslan, Niven Mehra, Francis Parnis, Emma Brown, Friederike Schlürmann, Jae Young Joung, Mikio Sugimoto, Oliver Sartor, Yuzhen Liu, Christian Poehlein, Laura Barker, Paula Michelle del Rosario, Andrew J. Armstrong - The Lancet Oncology 2023 被引用: 288
- Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
著者: Andrew J. Armstrong, Arun Azad, Taro Iguchi, Russell Z. Szmulewitz, Daniel P. Petrylak, Jeffrey M. Holzbeierlein, Arnauld Villers, Antonio Alcaraz, B. Yа. Alekseev, Neal D. Shore, F. Gómez-Veiga, Brad Rosbrook, Fabian Zohren, Shunsuke Yamada, Gabriel P. Haas, Arnulf Stenzl - Journal of Clinical Oncology 2022 被引用: 299
- NCCN Guidelines Insights: Prostate Cancer, Version 1.2021
著者: Edward M. Schaeffer, Sandy Srinivas, Emmanuel S. Antonarakis, Andrew J. Armstrong, Justin E. Bekelman, Heather H. Cheng, Anthony V. D’Amico, Brian J. Davis, Neil Desai, Tanya B. Dorff, James A. Eastham, Thomas A. Farrington, Xin Gao, Eric M. Horwitz, Joseph E. Ippolito, Michael Kuettel, Joshua M. Lang, Rana R. McKay, Jesse K. McKenney, George J. Netto, David F. Penson, Julio M. Pow‐Sang, Robert E. Reiter, Sylvia Richey, Mack Roach, Stan Rosenfeld, Ahmad Shabsigh, Daniel E. Spratt, Benjamin A. Teply, Jonathan D. Tward, Dorothy A. Shead, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2021 被引用: 530
- Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
著者: Silke Gillessen, Alberto Bossi, Ian D. Davis, Johann S. de Bono, Karim Fizazi, Nicholas D. James, Nicolas Mottet, Neal D. Shore, Eric J. Small, Matthew R. Smith, Christopher J. Sweeney, Bertrand Tombal, Emmanuel S. Antonarakis, Ana M. Aparicio, Andrew J. Armstrong, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Pierre Blanchard, Alberto Briganti, Robert G. Bristow, Muhammad Bulbul, Orazio Caffo, Daniel Castellano, Elena Castro, Heather H. Cheng, Kim N., Simon Chowdhury, Caroline S. Clarke, Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind Mrabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Journal of Cancer 2023 被引用: 157
- Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
著者: James L. Mohler, Emmanuel S. Antonarakis, Andrew J. Armstrong, Anthony V. D’Amico, Brian J. Davis, Tanya B. Dorff, James A. Eastham, Charles A. Enke, Thomas A. Farrington, Celestia S. Higano, Eric M. Horwitz, Michael E. Hurwitz, Joseph E. Ippolito, Christopher J. Kane, Michael Kuettel, Joshua M. Lang, Jesse K. McKenney, George J. Netto, David F. Penson, Elizabeth R. Plimack, Julio M. Pow‐Sang, Thomas J. Pugh, Sylvia Richey, Mack Roach, Stan Rosenfeld, Edward M. Schaeffer, Ahmad Shabsigh, Eric J. Small, Daniel E. Spratt, Sandy Srinivas, Jonathan D. Tward, Dorothy A. Shead, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2019 被引用: 1,573
- Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer
著者: Daniel E. Spratt, Siyi Tang, Yilun Sun, Huei–Chung Huang, Emmalyn Chen, Osama Mohamad, Andrew J. Armstrong, Jonathan D. Tward, Paul L. Nguyen, Joshua M. Lang, Jingbin Zhang, Akinori Mitani, Jeffry Simko, Sandy DeVries, Douwe van der Wal, Hans Pinckaers, Jedidiah M. Monson, Holly A. Campbell, James A. Wallace, Michelle Ferguson, Jean-Paul Bahary, Edward M. Schaeffer, Howard M. Sandler, Phuoc T. Tran, Joseph P. Rodgers, Andre Esteva, Rikiya Yamashita, Felix Y. Feng - NEJM Evidence 2023 被引用: 120
- RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis
著者: Mu‐En Wang, Jiaqi Chen, Yi Lu, Alyssa Bawcom, Jinjin Wu, Jianhong Ou, John M. Asara, Andrew J. Armstrong, Qianben Wang, Lei Li, Yuzhuo Wang, Jiaoti Huang, Ming Chen - Journal of Clinical Investigation 2023 被引用: 102
- Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study
著者: Andrew J. Armstrong, Susan Halabi, Jun Luo, David M. Nanus, Paraskevi Giannakakou, Russell Z. Szmulewitz, Daniel C. Danila, Patrick Healy, Monika Anand, Colin Rothwell, Julia Rasmussen, Blair Thornburg, William R. Berry, Rhonda Wilder, Changxue Lu, Yan Chen, John L. Silberstein, Gabor Kemeny, Giuseppe Galletti, Jason A. Somarelli, Santosh Gupta, Simon G. Gregory, Howard I. Scher, Ryan Dittamore, Scott T. Tagawa, Emmanuel S. Antonarakis, Daniel J. George - Journal of Clinical Oncology 2019 被引用: 364
- Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study
著者: William K. Kelly, Daniel C. Danila, Chia‐Chi Lin, Jae‐Lyun Lee, Nobuaki Matsubara, Patrick J. Ward, Andrew J. Armstrong, David Pook, Miso Kim, Tanya B. Dorff, Stefanie Fischer, Yung‐Chang Lin, Lisa G. Horvath, Christopher Sumey, Zhao Yang, Gabor Jurida, Kristen M. Smith, Jamie N. Connarn, Hweixian Leong Penny, Julia Stieglmaier, Leonard J. Appleman - Cancer Discovery 2023 被引用: 97
- Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer
著者: Susan Halabi, William Kevin Kelly, Hua Ma, Hao Zhou, Nicole Solomon, Karim Fizazi, Catherine M. Tangen, Mark Rosenthal, Daniel P. Petrylak, Maha Hussain, Nicholas J. Vogelzang, Ian M. Thompson, Kim N., Johann S. de Bono, Andrew J. Armstrong, Mario A. Eisenberger, Abderrahim Fandi, Shaoyi Li, John C. Araujo, Christopher J. Logothetis, David I. Quinn, Michael J. Morris, Celestia S. Higano, Ian F. Tannock, Eric J. Small - Journal of Clinical Oncology 2016 被引用: 463
- A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers
著者: Himisha Beltran, Clara Oromendia, Daniel C. Danila, Bruce Montgomery, Christopher Hoimes, Russell Z. Szmulewitz, Ulka N. Vaishampayan, Andrew J. Armstrong, Mark N. Stein, Jacek Pinski, Juan Miguel Mosquera, Verena Sailer, Rohan Bareja, Alessandro Romanel, Naveen Gumpeni, Andrea Sboner, Étienne Dardenne, Loredana Puca, Davide Prandi, Mark A. Rubin, Howard I. Scher, David S. Rickman, Francesca Demichelis, David M. Nanus, Karla V. Ballman, Scott T. Tagawa - Clinical Cancer Research 2018 被引用: 275
- Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer from the PREVAIL Trial
著者: Andrew J. Armstrong, Ping Lin, Bertrand Tombal, Fred Saad, Celestia S. Higano, Anthony M. Joshua, Teresa Parli, Brad Rosbrook, Steve van Os, Tomasz M. Beer - European Urology 2020 被引用: 163
- Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study
著者: Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf, Yohann Loriot, Cora N. Sternberg, Celestia S. Higano, Peter Iversen, Christopher P. Evans, Choung‐Soo Kim, Go Kimura, Kurt Miller, Fred Saad, Anders Bjartell, Michael Borre, Peter F.A. Mulders, Teuvo L.J. Tammela, Teresa Parli, Suha Sari, Steve van Os, Ad Theeuwes, Bertrand Tombal - European Urology 2016 被引用: 419
- Fragmentomic analysis of circulating tumor DNA-targeted cancer panels
著者: Kyle T. Helzer, Marina N. Sharifi, Jamie M. Sperger, Yue Shi, Matti Annala, Matthew L. Bootsma, Steve Reese, Amy K. Taylor, Katherine R. Kaufmann, Hannah Krause, Jennifer L. Schehr, N. Sethakorn, David Kosoff, Christos E. Kyriakopoulos, Mark E. Burkard, Nicholas R. Rydzewski, Menggang Yu, Paul M. Harari, M. Bassetti, Grace C. Blitzer, John M. Floberg, Martin Sjöström, David A. Quigley, Scott M. Dehm, Andrew J. Armstrong, Himisha Beltran, Rana R. McKay, Felix Y. Feng, Ruth O’Regan, Kari B. Wisinski, Hamid Emamekhoo, Alexander W. Wyatt, Joshua M. Lang, Shuang G. Zhao - Annals of Oncology 2023 被引用: 65
- Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas
著者: Mohit Kumar Jolly, Jason A. Somarelli, Maya U. Sheth, Adrian Biddle, S. C. Tripathi, Andrew J. Armstrong, Samir Hanash, Sharmila A. Bapat, Annapoorni Rangarajan, Herbert Levine - Pharmacology & Therapeutics 2018 被引用: 337
- Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
著者: Silke Gillessen, Alberto Bossi, Ian D. Davis, Johann S. de Bono, Karim Fizazi, Nicholas D. James, Nicolas Mottet, Neal D. Shore, Eric J. Small, Matthew R. Smith, Christopher J. Sweeney, Bertrand Tombal, Emmanuel S. Antonarakis, Ana M. Aparicio, Andrew J. Armstrong, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Pierre Blanchard, Alberto Briganti, Robert G. Bristow, Muhammad Bulbul, Orazio Caffo, Daniel Castellano, Elena Castro, Heather H. Cheng, Kim N., Simon Chowdhury, Caroline S. Clarke, Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia S. Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raya Leibowitz‐Amit, Christopher J. Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind Mrabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver A. Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Urology 2022 被引用: 118
- Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
著者: Yanjing Li, Yiping He, William Butler, Lingfan Xu, Yan Chang, Kefeng Lei, Hong Zhang, Yinglu Zhou, Allen C. Gao, Qingfu Zhang, Daniel Taylor, Donghui Cheng, Suzette Farber-Katz, Rachid Karam, Tyler Landrith, Bing Li, Sitao Wu, Vickie Hsuan, Qing Yang, Hailiang Hu, Xufeng Chen, Melissa Flowers, Shannon J. McCall, John K. Lee, B. Smith, Jung Wook Park, Andrew S. Goldstein, Owen N. Witte, Qianben Wang, Matthew B. Rettig, Andrew J. Armstrong, Qing Cheng, Jiaoti Huang - Science Translational Medicine 2019 被引用: 136
- Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
著者: Andrew J. Armstrong, Susan Halabi, Tim Eisen, Samuel Broderick, Walter M. Stadler, Robert J. Jones, Jorge A. García, Ulka N. Vaishampayan, Joel Picus, Robert E. Hawkins, John D. Hainsworth, Christian Kollmannsberger, Theodore F. Logan, Igor Puzanov, Lisa Pickering, Christopher W. Ryan, Andrew Protheroe, Christine M. Lusk, Sadie Oberg, Daniel J. George - The Lancet Oncology 2016 被引用: 424
- CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial
著者: Andrew J. Armstrong, Ravit Geva, Hyun Cheol Chung, Charlotte Lemech, Wilson H. Miller, Aaron R. Hansen, Jong Seok Lee, Frank Tsai, Benjamin Solomon, Tae Min Kim, Christian Rolfo, Vincent L. Giranda, Yixin Ren, Fang Liu, Bhargava Kandala, Tomoko Freshwater, Judy S. Wang - Investigational New Drugs 2024 被引用: 62
